Sherlock Biosciences Announces Close of Series A Round with Additional Investment Led by Northpond Ventures and Baidu Ventures

Gene editing

Home » Emerging technologies » Gene editing

EdiGENE Raises $15 million in Series B Funding

Tokyo Japan and Cambridge, Mass. –April 10th, 2019–EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for treatment of genetic disorders, announced todaythat it has raised 1.6 Billion-yen...

Cibus Issued New Patent Covering Its Gene-Editing Technologies In Plants

Inscripta adds $20M to its $105M Series C to create CRISPR-powered gene editing tools

Gene editing company Inscripta’s vision is to “operationalize” biology with its CRISPR-powered tools. It got one step closer today with the announcement of $20M in additional Series C funding, bringing their Series C to...

Inscripta Completes $20M Expansion of Series C Financing, Increasing Total Round to $105.5M

Amfora Licenses Gene Editing Technology

GenScript Launches Single-stranded DNA Service for CRISPR-based Gene Editing

Can synthetic biology usher in the next generation of anti-doping measures?

CRISPR superathletes: the future of bioengineered performance humans

Tropic Biosciences launches breakthrough GEiGS™ platform to combat global crop protection challenges by combining gene editing and RNAi technologies

News Digest #266 – Who owns CRISPR, exploring the synthetic biology IP landscape with Mintz (sponsored by Mintz)

gene editing

With the recent patent news, who owns CRISPR now?

Synthego

Synthego to award $1M in CRISPR tools to genome innovators

Caribou Biosciences Announces Expansion of Scientific Advisory Board

Cells

The CRISPR twins: bioethics for the gene-editing age

Horizon Discovery extends CRISPR Screening Service to primary human T cells